trial · primary record
Guselkumab
Crohn's Disease
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 120 |
| Primary completion | 2028-03-06 |
| Primary endpoint | Percentage of Participants Achieving a Magnetic Resonance Index of Activity (MaRIA) Less Than (<)11 in All Intestinal Segments at Week 48 |
| Registry ID | NCT06408935 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:32.691Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06408935
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Guselkumab · approval
- Guselkumab · compound